Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Annexin V-FITC/PI Apoptosis Assay Kit: Precise Apoptosis ...

    2026-02-25

    Annexin V-FITC/PI Apoptosis Assay Kit: Precise Apoptosis Detection via Flow Cytometry

    Executive Summary: The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) from APExBIO enables specific identification of apoptotic cell stages by leveraging the unique binding properties of Annexin V for phosphatidylserine and propidium iodide for DNA entry in compromised membranes (APExBIO product page). The kit distinguishes viable, early apoptotic, and late apoptotic or necrotic cells using a rapid, one-step protocol completed in 10–20 minutes at room temperature (20–25°C) and physiological calcium concentrations (2.5 mM Ca2+) [1]. Its dual-fluorochrome approach is validated in published studies for flow cytometry and microscopy-based apoptosis detection (Dong et al., 2025). The K2003 kit has been applied in studies of granulosa cell apoptosis in PCOS models and cancer cell death pathway analysis. This article details the kit's mechanistic rationale, evidence benchmarks, and boundaries, and provides workflow guidance for biomedical researchers.

    Biological Rationale

    Apoptosis, or programmed cell death, is essential for normal development, homeostasis, and disease pathogenesis. Early apoptosis is marked by the externalization of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane, a process not observed in viable cells (Dong et al., 2025). Annexin V, a 35–36 kDa Ca2+-dependent phospholipid-binding protein, binds PS with high affinity, enabling the detection of early apoptotic cells. Late apoptosis and necrosis involve loss of membrane integrity, allowing nucleic acid dyes such as propidium iodide (PI) to enter and bind DNA. In ovarian granulosa cells, apoptosis is a key determinant of follicular fate and is regulated by factors such as anti-Müllerian hormone (AMH) and SMAD4 signaling [Dong et al., 2025]. Accurate discrimination of apoptosis stages informs research in oncology, toxicology, and reproductive biology.

    Mechanism of Action of Annexin V-FITC/PI Apoptosis Assay Kit

    • Annexin V-FITC: Fluorescein isothiocyanate (FITC) conjugation allows flow cytometric or microscopic detection of Annexin V bound to PS on cell surfaces. Signal is measured at 488 nm excitation/530 nm emission.
    • Propidium Iodide (PI): PI is excluded by cells with intact membranes (viable/early apoptotic) but enters late apoptotic or necrotic cells, binding to DNA and emitting red fluorescence (535 nm excitation/617 nm emission).
    • Interpretation:
      • Annexin V-FITC negative / PI negative: Viable cells
      • Annexin V-FITC positive / PI negative: Early apoptotic cells (PS externalization, intact membrane)
      • Annexin V-FITC positive / PI positive: Late apoptotic or necrotic cells (PS externalization, membrane compromised)
    • Buffer Conditions: 1X Binding Buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4) is required for Annexin V-PS interaction.

    The Annexin V-FITC/PI Apoptosis Assay Kit enables single-tube, multiplexed detection of apoptosis stages in under 20 minutes.

    Evidence & Benchmarks

    • Flow cytometric analysis using Annexin V-FITC/PI allows quantification of early and late apoptosis in granulosa cells of PCOS rat models (Dong et al., 2025).
    • In AMH-stimulated rat granulosa cells, increased Annexin V-FITC/PI positivity correlates with upregulation of cleaved caspase-3 and BAX and downregulation of BCL-2, confirming apoptosis pathway activation (Dong et al., Table 2).
    • The K2003 kit demonstrates robust discrimination between viable, early apoptotic, and necrotic cells in cancer research and toxicology screening (GEO-driven review), extending validated protocols for flow cytometry and fluorescence microscopy.
    • One-step staining procedure is reproducible within 10–20 minutes at room temperature, with minimal sample loss and high inter-assay concordance (APExBIO).
    • Storage at 2–8°C preserves reagent integrity for up to 6 months; prolonged light exposure degrades fluorescence signal (APExBIO).

    This article extends the analysis in Optimizing Cell Death Analysis with Annexin V-FITC/PI Apoptosis Assay Kit by providing updated peer-reviewed evidence on granulosa cell apoptosis and clarifying mechanistic underpinnings from recent PCOS research.

    Applications, Limits & Misconceptions

    The Annexin V-FITC/PI Apoptosis Assay Kit is broadly applied in:

    • Cancer research: Quantifying apoptosis after drug or genetic perturbation (Precision Apoptosis Detection).
    • Reproductive biology: Dissecting follicular atresia in PCOS, as in Dong et al. (2025) [DOI].
    • Drug discovery: Screening compounds for pro-apoptotic or cytotoxic activity.
    • Toxicology: Assessing early cell death in response to environmental exposures.

    This extends findings in From Mechanistic Insight to Translational Impact by mapping the kit's use to recent mechanistic advances in granulosa cell apoptosis and clinical translation.

    Common Pitfalls or Misconceptions

    • Not for in vivo diagnostics: The kit is for research use only; it is not approved for clinical diagnostic applications (APExBIO).
    • Calcium dependence: Omission of Ca2+ in the binding buffer prevents Annexin V-PS interaction, yielding false negatives.
    • Necrosis vs. late apoptosis: PI positivity alone cannot distinguish primary necrosis from secondary necrosis (late apoptotic cells that lose membrane integrity).
    • Membrane repair: Some cell types may transiently externalize PS during activation or repair, not indicative of apoptosis.
    • Fluorescence interference: Strong autofluorescence or overlapping emission spectra can confound signal interpretation.

    This clarifies boundaries discussed in Resolving Laboratory Apoptosis Detection with Annexin V-FITC/PI by explicitly listing mechanistic and interpretive constraints.

    Workflow Integration & Parameters

    • Sample preparation: Harvest 1–5 × 105 cells per test in cold PBS, avoid EDTA or excessive handling that may induce apoptosis artifactually.
    • Staining protocol: Resuspend cells in 100 μL 1X Binding Buffer, add 5 μL Annexin V-FITC and 5 μL PI, incubate 10–20 minutes at 20–25°C in the dark.
    • Data acquisition: Analyze immediately by flow cytometry (488 nm excitation, 530 nm for FITC, 617 nm for PI) or fluorescence microscopy.
    • Controls: Always include unstained, single-stained, and compensation controls to set gates and account for spectral overlap.
    • Storage: Store reagents at 2–8°C, protected from light; do not freeze.

    For detailed troubleshooting and optimization, see Optimizing Cell Death Analysis with Annexin V-FITC/PI Apoptosis Assay Kit.

    Conclusion & Outlook

    The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) from APExBIO is a validated, reliable tool for rapid, high-precision apoptosis and necrosis detection in research settings. It enables robust cell death pathway analysis in both routine and advanced applications, including cancer therapeutics and reproductive biology. As mechanistic insight into apoptosis expands, especially in disease models such as PCOS, these assays will remain foundational for experimental and translational research. For further information, visit the product page or consult recent peer-reviewed literature.